Tag: Japanese Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Companies

Japan Non-Alcoholic Steatohepatitis (Nash) Therapeutics And Diagnostics Market was valued at USD 1.1 Billion in 2024 and is estimated to reach USD 3.5 Billion by 2033, growing at a CAGR…